Aprea Therapeutics, Inc.·4

Oct 7, 7:29 PM ET

ROCKLAGE SCOTT M 4

4 · Aprea Therapeutics, Inc. · Filed Oct 7, 2019

Insider Transaction Report

Form 4
Period: 2019-10-07
Transactions
  • Conversion

    Common Stock

    2019-10-07+1,913,9101,926,073 total(indirect: See footnotes)
  • Conversion

    Common Stock

    2019-10-07+79,74680,253 total(indirect: See footnotes)
  • Conversion

    Common Stock

    2019-10-07+492,4752,418,548 total(indirect: See footnotes)
  • Conversion

    Common Stock

    2019-10-07+20,519100,772 total(indirect: See footnotes)
  • Conversion

    Series B Convertible Preferred Stock

    2019-10-071,913,9100 total(indirect: See footnotes)
    Common Stock (1,913,910 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2019-10-0779,7460 total(indirect: See footnotes)
    Common Stock (79,746 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2019-10-07492,4750 total(indirect: See footnotes)
    Common Stock (492,475 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2019-10-0720,5190 total(indirect: See footnotes)
    Common Stock (20,519 underlying)
Footnotes (4)
  • [F1]These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Common Stock ("Common Stock"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date.
  • [F2]Shares are held directly by 5AM Ventures IV, L.P.
  • [F3]Shares are held directly by 5AM Co-Investors IV, L.P.
  • [F4]5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM Funds"). The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4